Medical Branch Innovations

Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company based in Galveston, Texas, dedicated to developing and commercializing innovative treatments for serious respiratory disorders and acute radiation exposure. Their groundbreaking research focuses on utilizing natural regenerative peptides to restore vascular function and activate normal stem cell populations in the body, accelerating tissue repair and preventing the damaging effects of trauma, disease, ischemia, and radiation exposure. With a strong emphasis on TP508 peptide technology, Chrysalis aims to address critical medical needs such as acute respiratory distress syndrome (ARDS), brain cancer, respiratory failure, and nuclear radiation exposure. Their novel peptide drug product, TP508, has shown promising results in reducing neural inflammation, restoring neural stem cells, mitigating vascular damage, hemorrhage, and inflammation, and increasing survival rates. Through their cutting-edge research and clinical trials, Chrysalis BioTherapeutics is at the forefront of revolutionizing medical treatments and saving lives through innovation.Generated from the website

Ansh Labs LLC is a leading manufacturer and developer of immunoassays, specializing in the identification and development of emerging biomarkers. With a dedicated team and a commitment to research, Ansh Labs offers highly specific assays with excellent sensitivities, providing rapid turnaround times and easy procedures for accurate results. Driven by a passion for a healthier future, Ansh Labs prides itself on its extensive product catalog, which includes a range of antibodies, antigens, and immunoassays for various research areas, such as reproductive function, growth factors, and neuronal disorders. With a focus on immunoassay development, Ansh Labs ensures the difference is in the results, offering scientists and researchers the certainty they seek in their research endeavors.Generated from the website

Castle Biosciences, Inc, located in Friendswood, TX, is a leading provider of innovative tests that empower healthcare providers and patients to make more informed care decisions. Their broad portfolio of tests focuses on various clinical areas, including dermatology, gastroenterology, mental health, and ophthalmology, providing personalized information that improves outcomes. With a commitment to scientific rigor, Castle Biosciences utilizes genomic insight and molecular profiling to deliver accurate diagnostic and treatment plan decisions. Their tests, such as DecisionDx-Melanoma and TissueCypher, provide objective data and risk-aligned treatment plans, leading to better patient outcomes. Through their innovative approach, Castle Biosciences aims to improve disease management and treatment decisions by leveraging a person's unique biology.Generated from the website